We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · November 29, 2020

One-Month Dual Antiplatelet Therapy Following PCI With Zotarolimus-Eluting Stents in Patients at High Bleeding Risk

Circulation: Cardiovascular Interventions

 

Additional Info

Circulation: Cardiovascular Interventions
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
Circ Cardiovasc Interv 2020 Nov 10;[EPub Ahead of Print], DE Kandzari, AJ Kirtane, S Windecker, A Latib, E Kedhi, R Mehran, MJ Price, A Abizaid, DI Simon, SG Worthley, A Zaman, JW Choi, R Caputo, M Kanitkar, B McLaurin, S Potluri, T Smith, D Spriggs, T Tolleson, T Nazif, M Parke, LC Lee, TH Lung, GW Stone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading